First Newsletter Published

The first newsletter of the PREDICTION-ADR consortium has been published. Read about the recent annual plenary meeting of the consortium held in Utrecht where the recent progress of the research was discussed. The PREDICTION-ADR team have also been active in defining the specific phenotypes of statin associated myopathy and ACE inhibitor induced angioedema at a workshop of international experts in Liverpool. The MOLGEN network led by PREDICTION-ADR investigator Ana Alfirevic is now ready to recruit patients, allowing data on adverse drug reactions to be gathered from hospitals right across the UK. PREDICTION-ADR partner PGXIS has been awarded a new grant to drive exciting research into developing new drugs for rheumatoid arthritis. Download newsletter …